tradingkey.logo

Artivion Inc

AORT
View Detailed Chart
46.600USD
-0.550-1.17%
Close 12/19, 16:00ETQuotes delayed by 15 min
2.21BMarket Cap
LossP/E TTM

Artivion Inc

46.600
-0.550-1.17%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.17%

5 Days

+3.28%

1 Month

+4.41%

6 Months

+56.90%

Year to Date

+62.99%

1 Year

+66.61%

View Detailed Chart

TradingKey Stock Score of Artivion Inc

Currency: USD Updated: 2025-12-19

Key Insights

Artivion Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 2/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 51.71.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Artivion Inc's Score

Industry at a Glance

Industry Ranking
2 / 208
Overall Ranking
29 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 7 analysts
Buy
Current Rating
51.714
Target Price
+17.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Artivion Inc Highlights

StrengthsRisks
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.82% year-on-year.
Undervalued
The company’s latest PE is -201.94, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 43.29M shares, increasing 0.07% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 14.72K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.99.

Artivion Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Artivion Inc Info

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Ticker SymbolAORT
CompanyArtivion Inc
CEOMackin (James Patrick)
Websitehttps://artivion.com/

FAQs

What is the current price of Artivion Inc (AORT)?

The current price of Artivion Inc (AORT) is 46.600.

What is the symbol of Artivion Inc?

The ticker symbol of Artivion Inc is AORT.

What is the 52-week high of Artivion Inc?

The 52-week high of Artivion Inc is 48.250.

What is the 52-week low of Artivion Inc?

The 52-week low of Artivion Inc is 21.970.

What is the market capitalization of Artivion Inc?

The market capitalization of Artivion Inc is 2.21B.

What is the net income of Artivion Inc?

The net income of Artivion Inc is -13.34M.

Is Artivion Inc (AORT) currently rated as Buy, Hold, or Sell?

According to analysts, Artivion Inc (AORT) has an overall rating of Buy, with a price target of 51.714.

What is the Earnings Per Share (EPS TTM) of Artivion Inc (AORT)?

The Earnings Per Share (EPS TTM) of Artivion Inc (AORT) is -0.231.
KeyAI